1. The biliary excretion of injected [14C]aniline, [14C]benzoic acid, 4-aminohippuric acid and 4-acetamidohippuric acid in six or eight species of animal (rat, dog, hen, cat, rabbit, guinea pig, rhesus monkey and sheep) was studied. 2. These compounds, with molecular weights in the range 93-236, are poorly excreted in the bile in all the species examined and, in effect, there is little significant species difference in the extent oftheir biliary excretion. 3. Compounds of higher molecular weight (355-495) were also studied, namely succinylsulphathiazole, [14C]stilboestrol glucuronide, sulphadimethoxine Nl-glucuronide and phenolphthalein glucuronide. 4. With these compounds a clear species difference in the extent of biliary excretion was found, the rat, dog and hen being good exeretors, the rabbit, guinea pig and monkey poor excretors, and the cat and sheep taking an intermediary position. 5. There was a general trend for biliary excretion to be higher in all species when the compounds were of higher molecular weight. 6. These results are discussed in their relation to species differences in drug metabolism.
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In the preceding papers (Abou-El-Makarem, Millburn, Smith & Williams, 1967a,b) some of the factors that affect the extent of biliary excretion of foreign compounds in the rat were elucidated. It was shown that a minimum molecular weight and the possession of a strongly polar anionic group were important factors in appreciable or extensive biliary excretion. A compound may possess these properties as such or may acquire them by metabolism. However, the pattern of biliary excretion in the rat may, or may not, apply to other species. Therefore we examined the extent of biliary excretion of eight selected compounds, namely aniline (mol.wt. 93), benzoic acid (mol.wt. 122), 4-aminohippuric acid (mol.wt. 194), 4-acetamidohippuric acid (mol.wt. 236), succinylsulphathiazole (mol.wt. 355), stilboestrol glucuronide (mol.wt. 445), sulphadimethoxine Nl-glucuronide (mol.wt. 487) and phenolphthalein glucuronide (mol.wt. 495), in eight species of animals, namely cat, dog, guinea pig, hen, monkey (rhesus), sheep, rabbit and rat. The first three compounds are of low molecular weight and are extensively metabolized, but their biliary excretion is low in the rat (Abou-ElMakarem et al. 1967b ). 4-Acetamidohippuric acid is a polar conjugate of low molecular weight that is not metabolized and is poorly excreted in the bile in the rat (Abou-El-Makarem et al. 1967b ). The last four compounds are of relatively high molecular weight and on injection into rats are excreted in the bile in appreciable amounts (Millburn et al. 1967a,b) . It is shown below that the dog and hen are similar to the rat, but that the cat and sheep, and the rabbit, guinea pig and rhesus monkey are different from the rat in the extent of biliary excretion of foreign compounds.
MATERIALS AND METHODS
Chemical&. [carboxy-14C] Benzoic acid (100,uc/mg.), [U-14C] aniline hydrogen sulphate (194,uc/mg.) (Fischer, Millburn, Smith & Williams, 1966 Millburn et al. 1967a,b) . The only compound used here whose properties were not described in the above papers is ornithuric acid, which was found to be a major metabolite of benzoic acid in hen bile. The L-(+ )-ornithuric acid used had m.p. 1820 and was a sample previously prepared in the Laboratory (Baldwin, Robinson & Williams, 1960) . It is readily distinguished chromatographically from benzoic acid, hippuric acid and benzoyl glucuronide by its Rp value in a solvent system consisting of butan-l-ol saturated with a mixture of equal volumes of 1*5 N-NH3 and 1-5M-(NH4)2CO3 (Fewster & Hall, 1951 1-4 (1-3-1.6) 3.3 (2.4-4.1) 6*7 (6-1-6.9) 3*0 (2-2-3.6) 3.4 (1.8-6*3) 0-7 (0.5-0.9) 0-5 (0.3-0. The biliary excretion of aniline (Table 3) is somewhat higher than that of benzoic acid. In the rat, guinea pig, rabbit and hen the excretion is 3-6% and the main metabolites in the bile are 4-aminophenol and its glucuronide (mol.wt. 285) with small amounts of the 2-isomer. In the dog and cat the output in the bile is much lower, the cat producing only unconjugated 2-aminophenol and the dog both 2-and 4-aminophenol and their glucuronides.
In Table 4 , the results for a conjugate, 4-aminohippuric acid, which can be further conjugated, are shown. The extent of biliary excretion is similar (1-7%) in four species, i.e. rat, guinea pig, rabbit and dog, and rather lower (0.5 and 0.7%) in the hen and cat. The acid is, in effect, poorly excreted in the bile of all six species. In the rat, guinea pig and rabbit the main metabolite in the bile is 4-acetamidohippuric acid; in the dog 4-aminohippuric acid is excreted in the bile unchanged and this is not unexpected, since the dog is unable to acetylate aromatic amino groups; the cat excretes roughly equal amounts of the free and acetylated compound; the hen produces mainly the unchanged acid with a small amount (5%) of the acetylated acid. Table 6 . The compounds were chosen for study because they are not metabolized to any great extent and are excreted in the bile mainly unchanged. In the rat, as already shown by Millburn et al. (1967a,b) , these compounds are excreted in the bile in large amounts. Table 6 shows that there is a distinct species difference in 
the extent of biliary excretion of these compounds. There is, however, a general trend in that, in all the species examined, biliary excretion tends to increase with increasing molecular weight, although this is obviously not the only factor involved. Let us examine each of the four compounds separately.
Succinyl8ulphathiazole. This is a polar compound of molecular weight 355 which is excreted in the bile unchanged. Table 6 shows that, as far as this compound is concerned, the eight species examined can be divided into three groups. The first group contains the rat, dog and hen, in which the biliary excretion is about 10-15% of the dose when given intraperitoneally and 20-30% when given intravenously. The second group contains the cat and sheep, in which the biliary excretion is 6-7%. The third group contains the rabbit, guinea pig and rhesus monkey, in which the excretion is less than about 1% of the dose. The material excreted in the bile in all the species is the same, namely unchanged succinylsulphathiazole.
[14C]Stilboestrol glucuronide. This compound has a higher molecular weight (445) than the preceding compound and the species can be divided into two groups. The rat, dog, hen and cat excrete this compound in large amounts (60-100%) in the bile, whereas the guinea pig and rabbit excrete 20-30%. It is to be noted that, though the guinea pig and rabbit excrete appreciable amounts of this com- pound in the bile, these amounts are only about one-third to one-quarter of those excreted by the other four animals. In all the species, except the dog and cat, stilboestrol glucuronide is excreted in the bile largely in the unchanged state. Sulphadimethoxine Nl-glucuronide. This glucuronide (mol.wt. 487) was examined in four species only since its supply was limited. Again the rat and dog, in which biliary excretion was about 40%, can be distinguished from the rabbit and guinea pig, in which the excretion was about 10%.
Phenolphthalein glucuronide. Of the four compounds examined, this one had the highest molecular weight (495). Again, the eight species can be divided into three groups, as for succinylsulphathiazole. In the rat, dog and hen the biliary excretion is about 50-90%, in the cat and sheep about 30% and in the rabbit, guinea pig and rhesus monkey about 5-15%.
The results obtained (Tables 2-6) suggest that compounds of low molecular weight are poorly excreted in the bile in all the species examined, but, when the molecular weight of a compound reaches or exceeds a minimum value, which is about 325 + 50, or when such a value can be attained by a metabolic change, then biliary excretion becomes appreciable and its extent depends on species. Of the eight species examined, it appears that they can be divided into three groups. The good biliary excretors of compounds of higher molecular weight are the rat, dog and hen, and the relatively poor biliary excretors are the rabbit, guinea pig and rhesus monkey. There is an intermediary group that are neither good nor poor biliary excretors, and the cat and sheep are in this group. The reasons for these species differences in the extent of biliary excretion are now being examined and a preliminary report has been published (Abou-El-Makarem, .
Species differences in the metabolism of foreign compounds frequently occur and are of considerable importance in the testing of the safety and activity of drugs, food additives, pesticides etc. for use by man. The choice of chemicals for safe use in man depends largely on tests in animals. Some of the reasons for species differences in drug metabolism, especially those of an enzymic nature, have been discussed by Williams (1967) . Differences in biliary excretion can also be an important reason for species differences in drug metabolism, for, in those species in which biliary excretion is extensive, high faecal excretion, enterohepatic circulation and metabolism by gut bacteria can be contributory causes of differences in drug metabolism (Smith, 1966 
